arrow
J

Jennifer Cautela

aix-marseille université
H指数:29
被引数:6,546

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Distinct Inflammatory Responses of hiPSC-Derived Endothelial Cells and Cardiomyocytes to Cytokines Involved in Immune Checkpoint Inhibitor-Associated Myocarditis

人源诱导多能干细胞来源的内皮细胞和心肌细胞对与免疫检查点抑制剂相关心肌炎相关的细胞因子的不同炎症反应

2025-09-200
OAAI
Immune checkpoint inhibitor-associated myocarditis: a novel risk score

免疫检查点抑制剂相关心肌炎:一种新型风险评分

2025-06-180
PRE
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis (vol 29, pg 3100, 2023)
2024-01-032
OA
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis (oct, 10.1038/s41591-023-02591-2, 2023)
2023-11-270
OA
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
2023-10-2622
PRE
Effectiveness of Simulation-Based Training on Transesophageal Echocardiography Learning The SIMULATOR Randomized Clinical Trial
2023-03-018
PRE
Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry
2022-12-019
OAAI
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)

2022 ESC与欧洲血液学协会 (EHA),欧洲治疗放射学和肿瘤学会 (ESTRO) 和国际心脏肿瘤学会 (ic-os) 合作制定的心脏肿瘤学指南欧洲心脏病学会 (ESC) 心脏肿瘤学工作组

2022-08-26506
OA
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis A Narrative Review
2021-11-0182
PREAI
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines

与癌症治疗相关的心血管毒性: 美国和欧洲心脏肿瘤学指南的实用方法

2020-09-15188
OAAI